O'GRADY BRENDAN P. (EVP, North America Commercial) sold 50.0% of their position (15.55K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $168.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/4/2021ACC: 0001209191-21-017764
Officer· EVP, North America Commercial
Since Sep 2018
-15.55K
Net shares
Net seller
$168.6K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
1.17K acquired · 16.71K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−15.09K
Price / share
$10.85
Trade value
$163.60K
% of position
50.4%
3/2/2021
29.95K→14.87K
Ordinary Shares
Direct
Shares
+1.17K
Price / share
—
Trade value
—
% of position
7.8%
3/3/2021
14.87K→16.03K
Ordinary Shares
Direct
Shares
−463.00
Price / share
$10.86
Trade value
$5.03K
% of position
2.9%
3/3/2021
16.03K→15.57K
Total
Net shares
−14.38K
Net value
-$168.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/2/2021 | S · Sale | −15.09K | $10.85 | $163.60K | 50.4% | 29.95K | 14.87K |
| Ordinary Shares Direct | 3/3/2021 | M · Option Exercise | +1.17K | — | — | 7.8% | 14.87K | 16.03K |
| Ordinary Shares Direct | 3/3/2021 | S · Sale | −463.00 | $10.86 | $5.03K | 2.9% | 16.03K | 15.57K |
| Total | −14.38K | -$168.63K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
1.17K shares
Shares
−1.17K
Strike price
Held after
0.00
Exercisable
—
3/3/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares1.17K shares | 3/3/2021 | M · Option Exercise | −1.17K | — | 0.00 |